Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andres F Muro

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Journal of Allergy and Clinical Immunology|December 21, 2010
The extra domain A of fibronectin is essential for allergen-induced airway fibrosis and hyperresponsiveness in miceMartin Kohan, Andres F Muro, Reem Bader, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 21, 2010
EDA-containing cellular fibronectin induces fibroblast differentiation through binding to alpha4beta7 integrin receptor and MAPK/Erk 1/2-dependent signalingMartin Kohan, Andres F Muro, Eric S White, et al.
The Journal of Biological Chemistry|July 13, 2004
An exonic splicing enhancer offsets the atypical GU-rich 3' splice site of human apolipoprotein A-II exon 3Pablo Arrisi-Mercado, Maurizio Romano, Andres F Muro, et al.
Gene Expression Patterns : GEP|December 7, 2011
Stam2 expression pattern during embryo developmentMarija Curlin, Katarina Kapuralin, Andres F Muro, et al.
The Journal of Cell Biology|July 9, 2003
Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespanAndres F Muro, Anil K Chauhan, Srecko Gajovic, et al.
Molecular Therapy. Methods & Clinical Development|October 11, 2016
A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndromeGiuseppe Ronzitti, Giulia Bortolussi, Remco van Dijk, et al.
Molecular Therapy. Methods & Clinical Development|February 2, 2019
Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar SyndromeFanny Collaud, Giulia Bortolussi, Laurence Guianvarc'h, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Journal of Allergy and Clinical Immunology|December 21, 2010
The extra domain A of fibronectin is essential for allergen-induced airway fibrosis and hyperresponsiveness in miceMartin Kohan, Andres F Muro, Reem Bader, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 21, 2010
EDA-containing cellular fibronectin induces fibroblast differentiation through binding to alpha4beta7 integrin receptor and MAPK/Erk 1/2-dependent signalingMartin Kohan, Andres F Muro, Eric S White, et al.
The Journal of Biological Chemistry|July 13, 2004
An exonic splicing enhancer offsets the atypical GU-rich 3' splice site of human apolipoprotein A-II exon 3Pablo Arrisi-Mercado, Maurizio Romano, Andres F Muro, et al.
Gene Expression Patterns : GEP|December 7, 2011
Stam2 expression pattern during embryo developmentMarija Curlin, Katarina Kapuralin, Andres F Muro, et al.
The Journal of Cell Biology|July 9, 2003
Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespanAndres F Muro, Anil K Chauhan, Srecko Gajovic, et al.
Molecular Therapy. Methods & Clinical Development|October 11, 2016
A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndromeGiuseppe Ronzitti, Giulia Bortolussi, Remco van Dijk, et al.
Molecular Therapy. Methods & Clinical Development|February 2, 2019
Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar SyndromeFanny Collaud, Giulia Bortolussi, Laurence Guianvarc'h, et al.
Pageof 1